• Overview
  • Details
  • More
Share Products Categories Channel Cart

1/6
(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical图1(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical图2(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical图3(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical图4(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical图5(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical图6

(R) -3-Amino-Y-Butyrolactone Hydrochloride CAS 117752-88-2 Fine Chemical

Price $10.00
Min Order 1 Piece  
Shipping from Jiangsu, China
Quantity
-+
Product details
Fine Chemical
117752-88-2
N/a
N/a
Synthesis Material Intermediates
Powder
Industrial
White
PUYER
Drum
99%
China
Product Description
Product Description

 

(R)-3-Amino-γ-butyrolactone hydrochloride is a chiral compound that is significant in the field of pharmaceuticals and organic chemistry. It is a derivative of γ-butyrolactone, which is a four-membered lactone ring, and the presence of the amino group provides it with specific reactivity and biological activity.

This compound can be used as a building block in the synthesis of more complex molecules, particularly in the development of pharmaceuticals that require chiral centers. The hydrochloride salt form of the compound enhances its solubility, which is an important consideration in drug development as it can affect the absorption and distribution of the drug within the body.

In the context of drug development, (R)-3-Amino-γ-butyrolactone hydrochloride could be used in the synthesis of various pharmaceutical agents, potentially including those for the treatment of neurological disorders, as γ-butyrolactone derivatives are known to have activity in such areas. The specific (R)-configuration indicates that it is the active isomer, which may exhibit different biological activity compared to its (S)-counterpart.

It is important to note that while this compound has potential applications in pharmaceutical development, the final drug products and their applications are subject to rigorous testing and regulatory approval before they can be used in clinical settings. The use of such intermediates is a critical aspect of the drug discovery and development process.

 
Detailed Photos

 

Buyer review
Loading review details...
Contact

Puyer Biopharma Ltd.

Audited Supplier13 Years
ProfileCertified by SGS/BV

Message Type

* Content

* Name

* Phone

* Email

* Captcha

captcha

Recommended for you